Xeptiva develops active immunization against validated targets of chronic pain and inflammation. A single platform, a partial and reversible response, and an effect that lasts for months.
Improve companion animals’ healthspan and lifespan
Simple, affordable and highly effective immunotherapies for the chronic conditions that affect companion animals’ quality of life.
Learn more about uspets live with chronic inflammatory conditions, such as osteoarthritisatopic dermatitisobesitycancer
Daily oral anti-inflammatories. Widely used and effective, but long-term use is limited by gastrointestinal and kidney tolerability.
Ready-made antibodies given by repeated injections. Real-world use has brought reports of unwanted side effects, so treated animals need close monitoring.
Fast control of itch and inflammation. Long-term use calls for regular monitoring, and symptoms tend to return when treatment stops.
Xeptiva’s immunogen trains the immune system to make its own antibodies, with a partial and reversible effect.
The immune system is trained to produce its own antibodies against the mediators of chronic inflammation.
Each immunogen neutralizes a disease mediator together with Substance P, the neuropeptide that activates mast cells and keeps neurogenic inflammation chronic.
A short priming course keeps antibody levels up for months, and a booster maintains them.
Made by recombinant fermentation, a simple and lower-cost process, and stored at 4 °C, so we can all benefit from innovative therapies.
Safety and efficacy trials in dogs and horses, completed and ongoing, run in Uruguay and Chile together with academic and clinical partners.
Whether through acquisition, licensing or co-development, we are looking for partners who share our goal of bringing long-lasting solutions to companion animals.
The company, the products, the platform, the patents and the team, with full technology transfer.
Rights to Xep01 or Xep02 in defined markets, with the development package and manufacturing transfer.
A new antigen for a new indication or species, run through the same pipeline in Montevideo.
Write to info@xeptiva.com or leave your details and we will answer within five business days.
